Mendus : Interim Report January - March 2024
English Swedish ...
Erik Manting Lotta Ferm Northx Biologics North Lymphoma Group Human Research Ethics Committee Northx Biologics
Source: marketscreener.com
📰 Erik Manting News
Erik Manting News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Erik Manting. Real-time updates on events, politics, business and more.
Mendus provides business update and outlook for vididencel program
Press Release Stockholm, Sweden, March 12, 2024 ADVANCE II Phase 2 trial data provide basis for late-stage development of lead product vididencel in acute myeloid leukemiaRegistration trial...
United States Erik Manting Lymphoma Group American Society For Hematology Northx Biologics Business Update
Source: marketscreener.com
Mendus to participate in upcoming industry conferences
Press release Stockholm, Sweden, February 27, 2024 Mendus AB , a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the...
New York United States San Diego Comunidad Autonoma De Cataluna Erik Manting Research Satwinder Kaur Singh
Source: marketscreener.com
Mendus to hold Business Update event on March 12
23.02.2024 - Press Release Stockholm, Sweden, February 23, 2024 Mendus AB (“Mendus” publ; IMMU.ST), will hold an in-person and live-streamed business update event in Stockholm on March 12, 15:00-17:00 CET to discuss the company’s latest pipeline ...
Source: wallstreet-online.de
Invitation to presentation of Mendus' year-end report for 2023 -February 09, 2024 at 02:03 am EST
Mendus AB , will publish its year-end report for 2023 on Wednesday 14 February 2024 at 08:00 CET. The company will hold a conference call and an online presentation on the same day at 10:00 CET. The...
Source: marketscreener.com
Mendus to participate in several investor and industry
Press release Stockholm, Sweden, January 8, 2024 Mendus AB (
United States San Francisco Erik Manting Healthcare Conference Annual Lifesci Partners Corporate Access Lifesci Corporate Access
Source: globenewswire.com
Mendus to participate in several investor and industry conferences in January
Press release Stockholm, Sweden, January 8, 2024 Mendus AB , a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the...
United States San Francisco Erik Manting Healthcare Conference Annual Lifesci Partners Corporate Access Lifesci Corporate Access
Source: marketscreener.com
Mendus announces clinical pipeline update
Press Release Stockholm, Sweden, December 22, 2023 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, announced an update on the status and outlook of...
United States Erik Manting American Society Of Hematology Annual Meeting Lymphoma Group American Society Hematology Annual Meeting
Source: marketscreener.com
Mendus AB: REPORT FROM THE EXTRAORDINARY GENERAL MEETING OF MENDUS AB (PUBL) ON 13 DECEMBER 2023 -December 13, 2023 at 11:00 am EST
Press Release Stockholm, Sweden, December 13, 2023 At the extraordinary general meeting of Mendus AB , reg. no. 556629-1786, , on 13 December 2023 the EGM adopted, inter alia,...
Source: marketscreener.com
Mendus announces positive survival data from Phase 2 ADVANCE II trial evaluating vididencel as maintenance therapy for AML at ASH 2023
Press Release Stockholm, Sweden, December 11, 2023 As of November 24, 2023, median relapse-free survival stood at 30.4 months Median overall survival was not reached, with the majority of...
Source: marketscreener.com